WO2023079528 - COMPOSITIONS SUITABLE FOR USE IN A METHOD FOR ELICITING CROSS-PROTECTIVE IMMUNITY AGAINST CORONAVIRUSES
National phase entry is expected:
Publication Number
WO/2023/079528
Publication Date
11.05.2023
International Application No.
PCT/IB2022/060699
International Filing Date
07.11.2022
Title **
[English]
COMPOSITIONS SUITABLE FOR USE IN A METHOD FOR ELICITING CROSS-PROTECTIVE IMMUNITY AGAINST CORONAVIRUSES
[French]
COMPOSITIONS APPROPRIÉES POUR UNE UTILISATION DANS UN PROCÉDÉ POUR DÉCLENCHER UNE IMMUNITÉ PROTECTRICE CROISÉE CONTRE DES CORONAVIRUS
Applicants **
KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY
Inventors
CHAHAL, Jasdave
MCPARTLAN, Justine
RUEPING, Magnus
EPPINGER, Jorg
RENN, Dominik
TALUKDER, Poulami
Priority Data
63/276,302
05.11.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2555 | |
| EPO | Filing, Examination, Granting | 14665 | |
| Japan | Filing, Examination, Granting | 2514 | |
| South Korea | Filing, Examination, Granting | 2710 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
28,384
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Immunogenic compositions and methods of use thereof, for eliciting an immune response against multiple coronaviruses, using a single vaccine composition are described. The compositions include an antigen from more than one pathogen, for example, more than one member of the β-coronavirus family, for example, SARS-CoV and MERS-CoV. Exemplary antigens include the receptor binding domain (RBD) of the coronavirus spike protein or a fragment thereof. The disclosed compositions are administered to a subject in need therefore, to generate an immune response against more than one pathogen, represented by the source of the antigens in the construct.[French]
L'invention concerne des compositions immunogènes et des procédés d'utilisation de celles-ci, pour déclencher une réponse immunitaire contre de multiples coronavirus, en utilisant une seule composition vaccinale. Les compositions comprennent un antigène provenant de plus d'un pathogène, par exemple, plus d'un membre de la famille des β-coronavirus, par exemple le SARS-CoV et le MERS-CoV. Des exemples d'antigènes comprennent le domaine de liaison au récepteur (RBD) de la protéine de spicule de coronavirus ou d'un fragment de celle-ci. Les compositions de l'invention sont administrées à un sujet en ayant besoin, pour générer une réponse immunitaire contre plus d'un pathogène, représentée par la source des antigènes dans la construction.